positive opinion AIDAC on isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis

On January 22, 2015 the Anti-Infective Drug Advisory Committee (AIDAC) gave a positive opinion on isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis. The hearing at FDA Headquarters in Washington DC can be accessed online through the following links.

http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMateria...

January 22, 2015, Meeting of the Anti-Infective Drugs Advisory
Committee (AIDAC) - Webcast Recording

The Center for Drug Evaluation and Research (CDER) provided a live webcast of the January 22, 2015, meeting of the Anti-Infective Drugs Advisory Committee.

A recording of the webcast can be found at the following address:

• Start of Meeting to Morning Break: https://collaboration.fda.gov/p9rzp8kdysh/

• Morning Break to Lunch Break: https://collaboration.fda.gov/p5kzjjfh4t3/

• Lunch Break to End of Meeting: https://collaboration.fda.gov/p4gxk2749st/

The webcast was broadcast using Adobe Connect. You can make sure your computer has the correct
plug-ins to view the webcast at this web site:
https://collaboration.fda.gov/common/help/en/support/meeting_test.htm